Come up with a name for your new list and we'll add to it:
Delenex Therapeutics was acquired by
Cell Medica on July 12, 2016.
Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Thereby Delenex aims at extending the benefits of proven antibody therapeutics …